Abbott Laboratories (ABT)

There should be plenty of long-term upside for these stocks for investors willing to ride out the storm.

These stocks offer great dividends and more.

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns - over the past six months, healthcare stocks have collectively shed 7.7%. This drop is a noticeable divergence from the S&P 500’s 5.5% return.

These stocks check off all the boxes for investors no longer receiving a paycheck.

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the medical devices & supplies - diversified stocks, including Abbott Laboratories (NYSE:ABT) and its peers.

As the summer months draw to a close, a familiar pattern emerges on Wall Street: the historical August-September slump. This seasonal weakness, particularly pronounced in the S&P 500, is once again contributing to a palpable sense of caution among financial analysts and investors. After a robust rally in recent

These companies have provided strong returns to long-term shareholders, but they aren't done yet.

The Caviar Cruise strategy identifies high-quality stocks like Abbott Labs (ABT) with steady growth, strong ROIC, low debt, and reliable cash flow for long-term investors.

Xtrackers SPXD ETF offers a balanced way to invest in S&P 500 without relying on tech giants like Nvidia. Its innovative approach prioritizes actual economic activity and has affordable fees.

These stocks offer juicy dividends, solid growth prospects, and stability.

Discover five unstoppable dividend stocks that could pay you for life, and why I wouldn't sell any of them!

Stay updated with the movements of the S&P500 index one hour before the close of the markets on Friday. Discover which stocks are leading as top gainers and losers in today's session.

Abbott Laboratories' dividend is safe, the pipeline is strong, and the outlook for growth is positive, making the July price dip a buying opportunity.

Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Friday. Stay informed about the market activity below.

Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top S&P500 gainers and losers in today's session.

Healthcare product and device company Abbott Laboratories (NYSE:ABT) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 7.4% year on year to $11.14 billion. Its non-GAAP profit of $1.26 per share was in line with analysts’ consensus estimates.

Curious about the top performers within the S&P500 index one hour before the close of the markets on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.